Placebo du FORXIGA 10 mg, Forxiga 10 mg film-coated tablets
APHP220826
Phase 3 small_molecule active
Quick answer
Placebo du FORXIGA 10 mg, Forxiga 10 mg film-coated tablets for Adult patients discharged alive from ICU with a decreased eGFR, and/or an AKI during ICU stay and/or an elevated NT-proBNP at discharge. is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients discharged alive from ICU with a decreased eGFR, and/or an AKI during ICU stay and/or an elevated NT-proBNP at discharge.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active